Introduction and methods, manufacture of therapeutic coagulation factor concentrates, safety data on which recommendations are based, licensing status, therapeutic guidelines, clinical audit and a review of the guidelines.

David Ginsburg, M.D: An article covering von Willebrand Factor, coagulation factor V, plasminogen activator inhibitor-1, primary pulmonary hypertension and bone marrow transplantation.

Information about these rare medical conditions, anticoagulant therapy, research and online forum.

Thomas G. DeLoughery Associate Professor of Medicine defines this term and does an in depth article.

Brief information about these hypercoagulability disorders including causes, treatment, and prognosis.

Features articles about blood coagulation disorders including activated protein C resistance, von Willbrand's disease, and hypercoagulability.

Information about this inherited disorder that causes abnormal bleeding including causes, treatment, and prognosis.

Provides brief information about this inherited bleeding disorder, which is similar to hemophilia. Includes causes, symptoms, and prognosis.

Brief information about this inherited bleeding disorder including causes, symptoms, and prognosis.

Also known as Hageman factor, this is a congenital coagulation disorder that causes prolonged coagulation in a test tube but does not cause abnormal bleeding. Includes brief information.

Features diagrams and information about the various thrombophilic genetic markers, general information about clotting, glossary, and list of research sources.

Information about topics related to the pathophysiology, pharmacology, and clinical aspects of bleeding, coagulation, and hemostasis, including information about recombinant coagulation Factor VIIa.

Background, causes, symptoms, and treatment of hypercoagulability.

American Academy of Family Physicians article discussing factors that contribute to excessive clotting.